Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Concepción Peraire"'
Autor:
Concepción Peraire, Álvaro Gimeno, Beatriz Clares, Roser Sanz, Mireia Mallandrich, Ana C. Calpena
Publikováno v:
International Journal of Pharmaceutics. 477:650-654
According to previous studies reporting the anesthetic/analgesic action of oral topical doxepin administration, this study evaluated a model of buccal permeation to determine the depth of delivery of doxepin into excised porcine buccal mucosa followi
Autor:
Concepción Peraire, Joaquim Ramis, Rosendo Obach, Iñaki F. Trocóniz, Josep-María Cendrós, María J. Garrido
Publikováno v:
The Journal of Clinical Pharmacology. 52:487-498
Acromegaly arises from excessive levels of growth hormone (GH), many of whose effects are mediated by stimulation of secretion of insulin-like growth factor 1 (IGF-1). Synthetic somatostatin analogues inhibit GH secretion. The objective of the study
Publikováno v:
Drug Metabolism and Disposition. 40:1268-1278
Irosustat is a first-generation, irreversible, steroid sulfatase inhibitor currently in development for hormone-dependent cancer therapy. To predict clinical drug-drug interactions between irosustat and possible concomitantly administered medications
Autor:
Juhyun Kim, Karla Johanning, Karen A. Veverka, James T. Dalton, Concepción Peraire, Josep Solà
Publikováno v:
Xenobiotica. 41:851-862
Toremifene is an effective agent for the treatment of breast cancer in postmenopausal women and is being evaluated for its ability to prevent bone fractures in men with prostate cancer taking androgen deprivation therapy. Due to the potential for dru
Autor:
Nuria Lloberas, Y. Armendariz, L. Pou, María J. Garrido, Concepción Peraire, Ana Caldés, Josep M. Grinyó, Helena Colom, Iñaki F. Trocóniz, S. Gil-Vernet
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
A population pharmacokinetics analysis was performed after intravenous ganciclovir and oral valganciclovir in solid organ transplant patients with cytomegalovirus. Patients received ganciclovir at 5 mg/kg of body weight (5 days) and then 900 mg of va
Autor:
Leyanis Rodríguez-Vera, Carlos Orlando Jacobo‐Cabral, Helena Colom Codina, Concepción Peraire Guitart, Niurys de Castro Suárez, Mayra Ramos-Suzarte, Eduardo Fernández-Sánchez, Jorge Luis Soriano, Gilberto Castañeda Hernández
Publikováno v:
Journal of clinical pharmacology. 55(8)
This study aimed (1) to develop a semimechanistic pharmacokinetic (PK) model for nimotuzumab in patients with advanced breast cancer and (2) to identify demographic, biochemical, and clinical predictive factors of the PK variability. Data from a phas
Autor:
Iñaki F. Trocóniz, Rosendo Obach, Cristina Segura, Concepción Peraire, María J. Garrido, Josep-María Cendrós, Paola Principe
Publikováno v:
Cancer Chemotherapy and Pharmacology. 57:727-735
Purpose: To determine the maximum tolerated dose (MTD) of intravenous (iv) diflomotecan administered once every 3 weeks, and to characterize the relationship between pharmacokinetics and neutropenic effect, using a semi-mechanistic pharmacokinetic/ph
Publikováno v:
Metabolism. 54:1276-1281
Somatostatin analogs are the first-line medical therapy for acromegaly, and the treatment of this disease has been simplified by the development of extended-release formulations of these analogs. Lanreotide is a somatostatin analog that is available
Publikováno v:
Pharmaceutical Research. 22:94-102
To estimate the applicability of transdermal drug permeation parameters in a finite-dose model for skin pre-treated with terpenes and to evaluate the enhancing effect of some terpene formulations on alprazolam permeation.In vitro enhancement of alpra
Autor:
Concepción Peraire, M. Montes, Rosendo Obach, M.J. Barbanoj, R. M. Antonijoan, J. Vallès, J. A. Cordero, F. Bismuth, R. CheZérif‐Cheikh, M.‐L. Torres
Publikováno v:
Journal of Pharmacy and Pharmacology. 56:471-476
The pharmacokinetics/tolerability of lanreotide Autogel have been evaluated. Healthy volunteers (n = 24) first received immediate-release lanreotide as a single subcutaneous (s.c.) injection. After two days, 40 or 60 mg lanreotide Autogel was injecte